Kyasanur Forest disease

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Kyasanur Forest disease
File:Kyasanur Forest disease virus ecology.jpg
Synonyms	N/A
Pronounce	N/A
Specialty	N/A
Symptoms	Fever, headache, muscle pain, vomiting, gastrointestinal bleeding
Complications	Hemorrhagic fever, encephalitis
Onset	3-8 days after exposure
Duration	1-2 weeks
Types	N/A
Causes	Kyasanur Forest disease virus
Risks	Exposure to tick bites, contact with infected animals
Diagnosis	Serology, PCR
Differential diagnosis	N/A
Prevention	Vaccination, avoiding tick bites
Treatment	Supportive care
Medication	N/A
Prognosis	Variable, can be severe
Frequency	Endemic in Karnataka, India
Deaths	Case fatality rate of 3-10%

Kyasanur forest disease (KFD) is a tick-borne viral haemorrhagic fever endemic to South-western part of India. The disease is caused by a virus belonging to the family Flaviviridae. KFDV is transmitted to humans through the bite of infected hard ticks (Haemaphysalis spinigera) which act as a reservoir of KFDV.

Cause

• Kyasanur Forest disease (KFD) is caused by Kyasanur Forest disease virus (KFDV), a member of the virus family Flaviviridae.

History

KFDV was identified in 1957 when it was isolated from a sick monkey from the Kyasanur Forest in Karnataka (formerly Mysore) State, India.

• Since then, between 400-500 humans cases per year have been reported.

Reservoir hosts

• Hard ticks (Hemaphysalis spinigera) are the reservoir of KFD virus and once infected, remain so for life.
• Rodents, shrews, and monkeys are common hosts for KFDV after being bitten by an infected tick. KFDV can cause epizootics with high fatality in primates.

Transmission

• Transmission to humans may occur after a tick bite or contact with an infected animal, most importantly a sick or recently dead monkey.
• No person-to-person transmission has been described.
• Large animals such as goats, cows, and sheep may become infected with KFD but play a limited role in the transmission of the disease.
• These animals provide the blood meals for ticks and it is possible for infected animals with viremia to infect other ticks, but transmission of KFDV to humans from these larger animals is extremely rare.
• Furthermore, there is no evidence of disease transmission via the unpasteurized milk of any of these animals.

Signs and Symptoms

• After an incubation period of 3-8 days, the symptoms of KFD begin suddenly with chills, fever, and headache.
• Severe muscle pain with vomiting, gastrointestinal symptoms and bleeding problems may occur 3-4 days after initial symptom onset. Patients may experience abnormally low blood pressure, and low platelet, red blood cell, and white blood cell counts.
• After 1-2 weeks of symptoms, some patients recover without complication. However, the illness is biphasic for a subset of patients (10-20%) who experience a second wave of symptoms at the beginning of the third week. These symptoms include fever and signs of
• neurological manifestations, such as severe headache, mental disturbances, tremors, and vision deficits.
• The estimated case-fatality rate is from 3 to 5% for KFD.

Risk of Exposure

• KFD has historically been limited to the western and central districts of Karnataka State, India.
• However, in November 2012, samples from humans and monkeys tested positive for KFDV in the southernmost district of the State which neighbors Tamil Nadu State and Kerala State, indicating the possibility of wider distribution of KFDV.
• Additionally, a virus very similar to KFD virus (Alkhurma hemorrhagic fever virus) has been described in Saudi Arabia.
• People with recreational or occupational exposure to rural or outdoor settings (e.g., hunters, herders, forest workers, farmers) within Karnataka State are potentially at risk for infection by contact with infected ticks. Seasonality is another important risk factor as more cases are reported during the dry season, from November through June.

Diagnosis

• Diagnosis can be made in the early stage of illness by molecular detection by PCR or virus isolation from blood. Later, serologic testing using enzyme-linked immunosorbent serologic assay (ELISA) can be performed.

Treatment

• There is no specific treatment for KFD, but early hospitalization and supportive therapy is important.
• Supportive therapy includes the maintenance of hydration and the usual precautions for patients with bleeding disorders.

Prevention

• A vaccine does exist for KFD and is used in endemic areas of India.
• Additional preventative measures include insect repellents and wearing protective clothing in areas where ticks are endemic